Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
How can narrative medicine be used to potentially improve outcomes for patients on dialysis?
Related Questions
How do you titrate midodrine in your patients with ESKD who suffer from intradialytic hypotension?
Would you use argatroban or citrate catheter lock in a patient with ESKD and HITT?
Would you recommend temporary transition to hemodialysis in a peritoneal dialysis patient who has risk factors, such as recurrent peritonitis, for the development of encapsulating peritoneal sclerosis?
What medications do you use to treat encapsulating peritoneal sclerosis?
How would you approach the timing of hemodialysis for an ESKD patient with no urgent indications who has NSTEMI with a troponin level of 10 ng/dl, has not had dialysis in 2 days, and is planned for left heart catheterization the next day?
How do you treat restless leg syndrome in patients with end-stage renal disease?
Is there a role for vadadustat in addition to an ESA in ESKD patients who are hyporesponsive to ESA’s alone?
Would you consider not returning the blood from the dialysis circuit as a strategy for managing polycythemia in a patient with ESKD on hemodialysis who has a hemoglobin level greater than 16 g/dL?
How often do you recommend basic metabolic panel checks in a hospitalized ESKD patient on thrice weekly hemodialysis and for whom hyperkalemia is not of major concern?
Do you recommend avoiding morphine in patients with ESKD?
